ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-42 Cr | ₹-21 Cr | ₹-21 Cr | ₹-16 Cr | ₹-15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-42 Cr |
| Mar2024 | ₹-21 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-16 Cr |
| Mar2021 | ₹-15 Cr |
How is Deferred Tax Assets / Liabilities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-42 Cr | Negative | |
| Mar2024 | ₹-21 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-16 Cr | Negative | |
| Mar2021 | ₹-15 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹21,123.5 Cr | -0.7% | 1.1% | -3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹403,052.0 Cr | 0.3% | -3.7% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,336.0 Cr | 2.4% | 6.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,311.0 Cr | -0.8% | -1.5% | 25.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,264.0 Cr | 7.9% | 4.6% | 4.6% | Stock Analytics | |
| CIPLA | ₹105,484.0 Cr | 5.5% | 5.4% | -18.5% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -0.7% |
1.1% |
-3.5% |
| SENSEX | -0.4% |
1.3% |
0.8% |
You may also like the below Video Courses